HIF-PHI
Showing 1 - 25 of 165
Anemia in Incident Dialysis Patients Trial in Changsha (HIF-PHI, Epoetin Alfa)
Not yet recruiting
- Anemia in Incident Dialysis Patients
- HIF-PHI
- Epoetin Alfa
-
Changsha, Hunan, ChinaDepartment of Nephrology, Second Xiangya Hospital, Central South
May 20, 2021
Capabilities of Perinatal Healthcare Institutions in Federation
Completed
- Prenatal Care
- Referral to Centre of Higher Organizational Level
-
Tešanj, Bosnia and HerzegovinaGeneral Hospital Tešanj
Sep 15, 2023
Prostate Cancer, PSMA, p2PSA Trial in Shanghai (Prostate biopsy)
Recruiting
- Prostate Cancer
- +2 more
- Prostate biopsy
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Apr 9, 2023
Breast Tumor Female Trial in Lyon (Phi-Bra prototype measurements)
Not yet recruiting
- Breast Neoplasm Female
- Phi-Bra prototype measurements
-
Lyon, France
- +1 more
Oct 10, 2022
Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)
Recruiting
- Anemia in Dialysis-dependent CKD Patients
-
Alexandria, EgyptAlexandria University
Oct 29, 2023
Unauthorized Data Access Trial in Baltimore (receiving an email)
Completed
- Unauthorized Data Access
- receiving an email
-
Baltimore, MarylandProtenus, Inc.
Feb 20, 2022
Hypoxia-induced Autophagy in the Pathogenesis of MAP
Not yet recruiting
- Hypoxia
- +3 more
- HIF 1α and LC3B expression and MMP-9 level
- (no location specified)
Apr 5, 2023
Anemia, Dialysis-Dependent Chronic Kidney Disease Trial in United States (vadadustat, epoetin alfa)
Terminated
- Anemia
- Dialysis-Dependent Chronic Kidney Disease
- vadadustat
- epoetin alfa
-
Bakersfield, California
- +17 more
Feb 2, 2021
Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined
Recruiting
- Prostate Cancer
- PSA
- p2PSA
- +2 more
-
Shanghai, Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiao Tong University Scho
May 5, 2022
NEC, Atresia, Malrotation Trial (Perfusion assessment by means of the SPY-PHI camera)
Not yet recruiting
- NEC
- +3 more
- Perfusion assessment by means of the SPY-PHI camera
- (no location specified)
Feb 3, 2023
A Research for Combination of Prostate Health Index and mpMRI
Not yet recruiting
- Prostate Cancer
- (no location specified)
Dec 16, 2021
Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and
Not yet recruiting
- Von Hippel-Lindau Disease
- 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
- (no location specified)
Mar 30, 2023
Normobaric Hypoxia, Hypoventilation, Normoxia Trial in Lisbon (Repeated sprint)
Not yet recruiting
- Normobaric Hypoxia
- +2 more
- Repeated sprint
-
Lisbon, PortugalFaculty of Human Kinetics
Nov 10, 2023
Solid Tumor, TNBC - Triple-Negative Breast Cancer Trial in Bengbu, Beijing (LAE005 + Afuresertib + Nab-Paclitaxel, LAE005 +
Recruiting
- Solid Tumor
- TNBC - Triple-Negative Breast Cancer
- LAE005 + Afuresertib + Nab-Paclitaxel
- +3 more
-
Bengbu, Anhui, China
- +1 more
May 19, 2022
MRI Prostate in Different Prostate Health Index (Phi) Values
Recruiting
- Prostate Cancer
-
Hong Kong, Hong KongPrince of Wales Hospital, Chinese University of Hong Kong
Jun 29, 2022
HIV/AIDS and Infections Trial in France (Recombinant human mAb (bNAbs), Placebo)
Not yet recruiting
- HIV/AIDS and Infections
- Recombinant human monoclonal antibody (bNAbs)
- Placebo
-
Bobigny, France
- +16 more
Mar 18, 2022
Peripheral Arterial Disease Trial in Louisville (Carnosine, Placebo)
Completed
- Peripheral Arterial Disease
- Carnosine
- Placebo
-
Louisville, KentuckyUniversity of Louisville
Aug 3, 2022
Predict Near Future Initiation of Bed Exit
Terminated
- Sleep
- Pressure sensitive pad
-
Atlanta, GeorgiaBudd Terrace
Sep 9, 2021
Total Antioxidant, Total Oxidant(Tos), Hypoxia Inducible
Not yet recruiting
- Carbon Monoxide Exposure
- low-flow anesthesia
- (no location specified)
Dec 18, 2022
NSCLC Trial in Houston (Amivantamab, Tepotinib)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023